Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
This is an observational (non-interventional), multi-center study that will prospectively enroll patients diagnosed with, and treated for Hodgkin lymphoma. Data collection will include extraction of medical records via case report forms, self-administered patient-reported outcome questionnaires, and tissue samples (archival and newly obtained) for molecular profiling. Treatment decisions will be determined at the discretion of the treating physician(s). As the study is collecting data on real-world management of cHL, the protocol is not to influence prescribing or management practices at participating sites in any way.
Condition | Lymphoma |
---|---|
Clinical Study Identifier | TX149248 |
Sponsor | Tetraphase Pharmaceuticals, Inc. |
Last Modified on | 25 March 2021 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.